Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
- 6 December 2022
- journal article
- review article
- Published by Elsevier BV in The Lancet Diabetes & Endocrinology
- Vol. 11 (1), 42-57
- https://doi.org/10.1016/s2213-8587(22)00319-9
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)Diabetes Technology & Therapeutics, 2013
- The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trialDiabetologia, 2012
- Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose MonitoringDiabetes Technology & Therapeutics, 2011
- Effectiveness of Continuous Glucose Monitoring in a Clinical Care EnvironmentDiabetes Care, 2009
- Hyperglycemic Crises in Adult Patients With DiabetesDiabetes Care, 2009
- Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of HypoglycemiaDiabetes Care, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993
- Physiological preparation for studying the response of subcutaneously implanted glucose and oxygen sensorsJournal of Biomedical Engineering, 1989
- Ambulatory Glucose Profile: Representation of Verified Self-Monitored Blood Glucose DataDiabetes Care, 1987
- The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility PhaseDiabetes, 1986